Paul Tudor Jones Biomarin Pharmaceutical Inc Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 57,750 shares of BMRN stock, worth $3.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

57,750

Previous 75,066 23.07%

Holding current value

$3.06 Million

Previous $5.31 Million 40.18%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$54.08 - $68.32 $936,449 - $1.18 Million	-17,316 Reduced 23.07%	57,750 $3.17 Million
Q1 2025 May 15, 2025	SELL	$61.25 - $72.83 $1.51 Million - $1.8 Million	-24,659 Reduced 24.73%	75,066 $5.31 Million
Q4 2024 Feb 14, 2025	BUY	$61.93 - $70.49 $430,847 - $490,398	6,957 Added 7.5%	99,725 $6.55 Million
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $6.4 Million - $8.71 Million	92,768 New	92,768 $6.52 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $3.16 Million - $4.24 Million	39,076 New	39,076 $4.04 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $570,124 - $692,715	-7,976 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $592,457 - $739,295	7,976 New	7,976 $615,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $210,402 - $240,512	-2,814 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $212,485 - $238,599	2,814 New	2,814 $235,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $1.28 Million - $1.56 Million	-17,187 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $970,650 - $1.21 Million	13,368 Added 350.04%	17,187 $1.51 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $274,471 - $500,403	3,819 New	3,819 $291,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $573,529 - $778,286	-8,036 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.85 Million - $2.48 Million	-28,771 Reduced 78.17%	8,036 $679,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $387,819 - $489,722	5,754 Added 18.53%	36,807 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $19,685 - $23,005	245 Added 0.8%	31,053 $2.66 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $445,418 - $521,699	5,290 Added 20.73%	30,808 $2.74 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $716,371 - $948,159	-8,939 Reduced 25.94%	25,518 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $1.58 Million - $1.78 Million	16,795 Added 95.09%	34,457 $3.34 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $1.34 Million - $1.75 Million	17,662 New	17,662 $1.66 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $805,670 - $960,850	-10,373 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $758,497 - $893,460	-9,392 Reduced 47.52%	10,373 $925,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.59 Million - $1.88 Million	19,765	19,765 $1.84 Million

Others Institutions Holding BMRN

# of Institutions

681

Shares Held

186M

Call Options Held

1.31M

Put Options Held

1.1M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $9.86B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account